Glutamate receptors in the rat medial prefrontal cortex regulate set-shifting ability

Behav Neurosci. 2003 Aug;117(4):728-37. doi: 10.1037/0735-7044.117.4.728.

Abstract

The authors examined set-shifting abilities in rats injected with antagonists of N-methyl-D-aspartate (NMDA) receptors (MK801) or alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors (LY293558) into the medial prefrontal cortex (mPFC). Set-shifting was assessed with a maze-based task requiring a switch between brightness and texture discrimination strategies. Intra-mPFC injection of MK801 prior to training on the 2nd discrimination impaired discrimination strategy acquisition. The MK801-induced deficit was due to increased perseverative responding. AMPA receptor blockade also impaired acquisition of the 2nd discrimination; these impairments were due to more general cognitive deficits. Results suggest that, within the mPFC, both AMPA and NMDA receptors are necessary for set-shifting, and that NMDA receptor hypofunction impairs the capacity to modify existing knowledge or to inhibit responses that are no longer appropriate.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cognition
  • Dizocilpine Maleate / pharmacology
  • Excitatory Amino Acid Antagonists / pharmacology
  • Isoquinolines / pharmacology
  • Male
  • Maze Learning*
  • Prefrontal Cortex / physiology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, AMPA / antagonists & inhibitors
  • Receptors, AMPA / physiology*
  • Receptors, N-Methyl-D-Aspartate / physiology*
  • Tetrazoles / pharmacology
  • Visual Perception

Substances

  • Excitatory Amino Acid Antagonists
  • Isoquinolines
  • Receptors, AMPA
  • Receptors, N-Methyl-D-Aspartate
  • Tetrazoles
  • Dizocilpine Maleate
  • tezampanel